Oppenheimer just released its 35 top stock ideas for October and November. Here’s a rundown of the full list with analyst commentary included.
1. Turtle Beach Corp HEAR
Analyst Sean McGowan sees two drivers of the stock: the “resurgence in video games” and the rollout of “directed audio” technology HyperSound.
2. Ulta Salon, Cosmetics & Fragrance, Inc. ULTA
Analyst Rupesh Parikh believes the company is capable of sustaining up to +7.0 percent comps and has “the potential to expand to more than 1,200 units over time.”
3. Home Depot Inc HD
Analyst Brian Nagel sees the company as “well positioned to capitalize upon improving demand trends in the home improvement sector.”
4. Darden Restaurants, Inc. DRI
5. Coach Inc COH
Analyst Anna Andreeva believes “COH is playing better offense, despite moderation in growth of [the] overall handbag category.”
6. Oneok Partners LP OKS
Analyst Bernard Colson believes “the current distribution is sustainable despite coverage ratio less than 1x.”
7. HollyFrontier Corp HFC
Analyst Fadel Gheit believes that the company’s “combination of refinery complexity, crude flexibility and growth markets gives HFC strong competitive advantages.”
8. Parsley Energy Inc PE
Analyst Robert DuBoff feels the stock “should trade at a premium to the E&P universe given its sizable drilling inventory and growth trajectory.”
9. Halliburton Company HAL
10. Citigroup Inc C
Analyst Chris Kotowski predicts that “earnings should grow above industry averages” as Citi Holdings is wound down.
11. Discover Financial Services DFS
Analyst Ben Chittenden pointed out that the stock is “trading at less than 10x 2016 consensus EPS, which equates to a 62 percent relative multiple to the S&P 500.”
12. Highwoods Properties Inc HIW
Analyst Steve Manaker believes “the market is underestimating HIW’s growth potential as its financial results should appreciate above expectations from portfolio expansion and improving market fundamentals.”
13. Cellectis SA (ADR) CLLS
14. Relypsa Inc RLYP
Analyst Ling Wang noted that the company’s pipeline is “substantially de-risked as lead asset Patiromer has achieved significant clinical validation.”
15. Teva Pharmaceutical Industries Ltd (ADR) TEVA
Analyst Akiva Felt feels “TEVA is emerging as a turnaround story fueled by business development opportunities that mesh well with the company’s existing strengths.”
16. Cerner Corporation CERN
Analyst Mohan Naidu sees the company “strengthening its market share position with consistent growth in new footprint and add-on sales.”
17. Community Health Systems CYH
18. Medtronic PLC MDT
19. KemPharm Inc KMPH
20. Proto Labs Inc PRLB
Analyst Holden Lewis praised the company’s “truly differentiated business model that enables it to tap the secular growth of rapid prototyping and generate strong margins and cash flow.”
21. Mobile Mini Inc MINI
22. SunPower Corporation SPWR
Analyst Colin Rusch views the company as “well-positioned to maintain its status as a pioneering solar platform.”
23. PowerSecure International, Inc. POWR
Analyst Noah Kaye sees the stock as a “diversified play on improving the efficiency of electricity production, distribution and consumption.”
24. Carlisle Companies, Inc. CSL
25. Honeywell International Inc. HON
26. Scholastic Corp SCHL
27. Xura Inc MESG
28. Ruckus Wireless Inc RKUS
29. Apple Inc. AAPL
30. Visa Inc V
31. Incontact Inc SAAS
32. Skyworks Solutions Inc SWKS
Analyst Rick Schafer believes the company is “rapidly transforming into a diversified analog semiconductor company enabling global connectivity and the Internet of Things.”
33. AT&T Inc. T
Analyst Timothy Horan believes the company has “the strongest balance sheet in the industry and an attractive dividend yield.”
34. Wix.Com Ltd WIX
Analyst Jason Helfstein forecasts “43 percent subscriber growth and 54 percent revenue growth from 2013 to 2016.”
35. Priceline Group Inc PCLN
Analyst Jed Kelly likes the company’s “superior business execution, strong presence in international markets […] and above-industry growth prospects.”
Disclosure: The author owns shares of Halliburton.
Image Credit: Public Domaindate | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.